Physician profile
Kyle P Smith
NPI 1306986484
$1,203.10
in general payments reported to CMS, 2019-2025
20 companies · $15.51 in 2025
The $15.51 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $71.65 · 2021: $446 · 2022: $169 · 2023: $228 · 2024: $131 · 2025: $15.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $260.87 | 2020-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $131.46 | 2024 | Proclaim |
| Globus Medical, INC. | $125.86 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $92.38 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $88.05 | 2023 | Quviviq |
| Medtronic, INC. | $84.77 | 2022 | |
| Intuitive Surgical, INC. | $71.81 | 2023 | Da Vinci Surgical System |
| Otsuka America Pharmaceutical, INC. | $67.74 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $38.34 | 2020-2021 | |
| Abbvie INC. | $37.23 | 2021 | |
| Medtronic USA, INC. | $30.00 | 2019 | |
| Amarin Pharma, INC. | $29.47 | 2021 | |
| Lilly USA, LLC | $24.46 | 2021 | |
| Pfizer INC. | $23.25 | 2021 | |
| Dexcom, INC. | $22.05 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.69 | 2021 | |
| Allergan, INC. | $17.04 | 2020 | |
| Apria Healthcare LLC | $13.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.16 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.